Completed
To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.
NCT02713243
- Conditions
- Primary Bile Acid Diarrhea
- Locations
-
- Novartis Investigative Site Rochester, Minnesota, United States
- Novartis Investigative Site Harrow, Middlesex, United Kingdom
- Novartis Investigative Site London, United Kingdom
- Novartis Investigative Site Sheffield, United Kingdom